Abbott Reveals Rising DKA Rates and Launches Dual Glucose‑Ketone Monitoring to Curb Delayed Diagnoses
Abbott’s new Libre Duo dual‑sensor glucose‑ketone system could curb rising DKA rates, especially in teens, by catching early signs before costly hospital stays.
3 minutes to read